Biotech

All Articles

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on stopped working epilepsy medicine, promotes FDA manage

.Our team actually recognize that Takeda is actually hoping to discover a course to the FDA for epil...

VBI Vaccinations files for insolvency, seeks asset purchase

.Immunology biotech VBI Injections is actually diverting hazardously near the point of no return, al...

Celldex anti-cKIT antibody lower hives in an additional stage 2 study

.It is actually hard to muscular tissue in on a space as reasonable as immunology, however Celldex T...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies and a preclinical invulnerabl...

Ventyx's last resort for inflamed med sides in Crohn's failing

.Ventyx Biosciences' Crohn's ailment medication did not aid individuals achieve remission in a phase...

Cognition's period 2 beam information blemish Alzheimer's possibility

.Cognition Therapies' phase 2 SHINE trial has actually taken several of the radiance off the Alzheim...

BMS centers bispecific months after submitting to function period 3 test

.Bristol Myers Squibb has actually possessed a whiplash change of mind on its own BCMA bispecific T-...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who managed Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers Squib...

Asarina to close after attempts to companion Tourette's medicine fall short

.After communicating to greater than 200 providers to companion a Tourette disorder therapy that pre...